This paper presents an experience of thirty consecutive patients with hepatic colorectal metastases who were treated with hepatic cryotherapy and subsequent hepatic arterial infusion (HAI) chemotherapy using 5 FU.
INTRODUCTION
Colorectal cancer is a common disease in New Zealand with approximately 2000 new cases being registered annually. Liver metastases are found at diagnosis in some 25% of patients with colorectal cancer [1] and another 25-40% will eventually develop metastases [2] . Median survival for patients with untreated colorectal hepatic metastases is 6 to 8 months from diagnosis, and less than 2% survive for 5 years [3] . Surgical resection of liver metastases confers a median survival of over two years and a 25-52% five-year survival rate [4] [5] [6] . However, because of the number and/or location of metastases within the liver, fewer than 25% of patients are candidates for resection [7] .
Cryotherapy with in-situ destruction of tumours is a possible treatment option. As a focal treatment, it spares more normal liver tissue than resection, thus allowing multiple lesions affecting both lobes of the liver to be treated.
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Good results have been achieved in patients with hepatocellular carcinoma [8] and encouraging results have been reported for patients with colorectal liver metastases [9 11 ].
Systemic chemotherapy regimens have been used for many years to treat metastatic colorectal cancer [12, 13] . The most active agent in this context is 5 fluorouracil (5 FU) . The addition of folinic acid, which augments the cytotoxic activity of 5FU and spares some toxicity, produces higher response rates than 5 FU alone. However, response rates remain less than 20% at the cost of significant systemic toxicity and there is little or no impact on survival [13, 14] . Hepatic arterial infusion (HAI) chemotherapy, in contrast, appears to be a more effective modality of treatment for non-resectable metastatic disease confined to the liver [15, 16] . In most studies, well over one third of the patients respond to this chemotherapy, and a median survival of 12-25months has been reported [16] [17] [18] [24] . In two trials crossover between treatment groups was allowed and patients who did not respond to systemic chemotherapy were switched to HAI chemotherapy to which many responded [25, 26] . The role of adjuvant HAI therapy after liver resection has also been examined in a randomised trial [27] [8] . Subsequently a number of encouraging.reports appeared in the literature concerning its use in the treatment of colorectal hepatic metastases [9] [10] [11] .
In the present series, patients were not candidates for liver resection because they had a median of 6 follow-up, the disease was progressive in 26 patients. However, as previously mentioned, patients who were regarded at one stage of follow up as having disease progression, frequently still had less disease than that shown by CT Scan prior to cryotherapy (Fig. 1) .
Eight patients died within 12 months of cryotherapy, 6 
